Alison Kay
Ali Kay is a CPM Junior Research Fellow. She is a multi-disciplinary researcher investigating perspectives and experiences of genetic and genomic testing, risk assessment and genetic therapies.
Current and recent projects:
- CureHeart – genetic therapies for inherited heart conditions
- ePREGCARE – genomic recurrence risk assessment strategy for couples after a child is diagnosed with a genetic condition caused by a de novo (new) genetic variant
- Adoptees and Direct-to-Consumer testing
She is an Elected Fellow, Royal Historical Society, and graduate member of Association of Genetic Nurses and Counsellors (AGNC) and British Psychological Society (BPS).
Recent publications
Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitioners
Alison C Kay, Jonathan Wells, Nina Hallowell, et al (2023), Journal of Medical Genetics, 60
Adoptees’ views and experiences of direct-to-consumer (DTC) genomic testing: an exploratory interview study from the UK
Alison Kay, Nicola V Taverner, Alison Kay, et al (2022), Journal of Community Genetics, 14
Adoptees’ views and experiences of direct-to-consumer (DTC) genomic testing: an exploratory interview study from the UK
Alison C Kay, Nicola V Taverner, Alison C Kay, et al (2022), Journal of Community Genetics, 14